AlTi Global’s AstraZeneca AZN Stock Holding History

AlTi Global’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$636K	Buy	+3,371	New	+$634K	0.01%	328
2026 Q1	–	Sell	-3,234	Closed	-$595K	–	444
2025 Q4	$595K	Buy	3,234 +1,228	+61%	+$215K	0.01%	289
2025 Q3	$308K	Sell	2,006 -358	-15%	-$54.2K	0.01%	370
2025 Q2	$332K	Buy	+2,364	New	+$331K	0.01%	346
2025 Q1	–	Sell	-1,567	Closed	-$206K	–	392
2024 Q4	$206K	Buy	+1,567	New	+$219K	0.01%	397

Other funds holding AZN

EPGL

Evelyn Partners Group Ltd London $46.9B AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

SAM

SEB Asset Management Stockholm $26.6B AUM

CDDEC

Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

AlTi Global's AZN Position: Q2 2026 in Review

AlTi Global opened a new position in AstraZeneca (AZN) in Q2 2026: 3,371 shares worth $636K. The stake represents 0.01% of the portfolio and ranks #328 among its holdings. This is a return to the name: AlTi Global previously reported a position in AZN as recently as Q4 2025.

AlTi Global first reported a position in AZN in Q4 2024 and has held it in 5 quarters since. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

AlTi Global held 3,371 shares of AstraZeneca worth $636K as of Q2 2026.
AstraZeneca was a new AlTi Global position in Q2 2026.
AstraZeneca made up 0.01% of AlTi Global's portfolio in Q2 2026, its #328 holding.
AlTi Global first reported a position in AstraZeneca in Q4 2024 and has held it in 5 quarters since.
906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on AlTi Global's 13F filing for Q2 2026, filed 5 Aug 2026.